Dr. Leschke

Publikationen

  • Clin Res Cardiol. 2010 Dec;99(12):809-15.
    Carotid artery interventions for restenosis after prior stenting: is it different from interventions of de novo lesions? Results from the carotid artery stent (CAS)--registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).
    Zahn R, Ischinger T, Zeymer U, Brachmann J, Jung J, Haase H, Hauptmann KE, Seggewiss H, Janicke I, Leschke M, Mudra H
  • Clin Res Cardiol. 2010 Mar;99(3):165-74.
    Treatment of small coronary arteries with a paclitaxel-coated balloon catheter.
    Unverdorben M, Kleber FX, Heuer H, Figulla HR, Vallbracht C, Leschke M, Cremers B, Hardt S, Buerke M, Ackermann H, Boxberger M, Degenhardt R, Scheller B
  • Anaesthesist. 2009 Oct;58(10):969-70.
    Perioperative management of patients with coronary stents undergoing non-cardiac surgery. Better to accept loss of blood than a cardiac infarct?
    Leschke M.
  • N Engl J Med. 2009 Sep 10;361(11):1045-57.
    Ticagrelor versus clopidogrel in patients with acute coronary syndromes.
    Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA; PLATO Investigators, Freij A, Thorsén M
  • Internist (Berl). 2009 Sep;50(9):1086, 1088-90, 1092-100. Review.
    Diagnostics in pulmonary Hypertension.
    Leschke M, Wädlich A, Waldenmaier S, Faehling M
  • Circulation. 2009 Jun 16;119(23):2986-94.
    Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis.
    Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B
  • Dtsch Med Wochenschr. 2008 Dec;133 Suppl 8:S270-3. Review.
    Rheology and coronary heart disease.
    Leschke M
  • Internist (Berl). 2007 Sep;48(9):948-60. Review.
    Right heart failure and cor pulmonale.
    Leschke M, Wädlich A
  • Dtsch Med Wochenschr. 2006 Aug 18;131(33):1827-8.
    Persistent CK-elevation after CSE inhibitor therapy.
    Faehling M, Leschke M
  • Clin Res Cardiol. 2006 Jan;95 Suppl 1:i98-102.
    Impaired glucose metabolism in patients with ischaemic heart disease.
    Leschke M, Schwenk B, Bollinger C, Faehling M
  • Dtsch Med Wochenschr. 2006 Feb 24;131(8):400-2.
    Recommendations for peri-procedural thrombocyte aggregation Inhibition.
    Sauer H, Leschke M
  • Dtsch Med Wochenschr. 2006 Feb 3;131(5):203-6.
    Acute femoral artery thrombosis after thrombin injection of a pseudoaneurysm.
    Wankmüller H, Ganschow U, Schneider A, Leschke M
  • Dtsch Med Wochenschr. 2004 Nov 19;129(47):2553-7. Review.
    Hyperglycemia and cardiovascular Events.
    Schneider CA, Gallwitz B, Hanefeld M, Leschke M, Müller-Wieland D, Zeymer U, Erdmann E
  • Dtsch Med Wochenschr. 2004 Oct 22;129(43):2320.
    Cardiac pacemaker in the catheter laboratory?
    Schneider A, Leschke M
  • Med Klin (Munich). 2003 Oct 15;98 Suppl 1:12-6.
    Does targeted therapy of type 2 diabetes prevent cardiovascular incidents?
    Leschke M
  • Dtsch Med Wochenschr. 2003 Dec 5;128(49):2612.
    Is there a connection between tooth diseases and diseases in a healthy heart?
    Brodbeck-Stoll K, Faehling M, Leschke M
  • Internist (Berl). 2003 Jul;44(7):853-63. Review.
    Rheological determinants of end-organ damage.
    Leschke M, Klimek W, Jung F
  • Dtsch Med Wochenschr. 2003 Oct 17;128(42):2213-4.
    How should anticoagulants be used in recurrent, ischemic and hemorrhagic brain infarctions?
    Leschke M, Klimek W
  • Dtsch Med Wochenschr. 2003 Oct 2;128(40):2093-4.
    Can a patient do heavy physical work after myocardial infarction?
    Leschke M, Klimek W
  • Dtsch Med Wochenschr. 2003 Jul 11;128(28-29):1562.
    Diagnosis and therapy of aneurysms of the atrial Septum.
    Wankmüller H, Leschke M
  • Dtsch Med Wochenschr. 2003 Apr 25;128(17):954.
    Which therapy should be followed for syncope with a positive tilt-table test?
    Ganschow U, Leschke M
  • Z Kardiol. 2002 Dec;91(12):1024-34.
    Alterations of left ventricular systolic and diastolic function in pregnant women with insulin-dependent diabetes mellitus.
    Schannwell CM, Zimmermann T, Marx R, Plehn G, Leschke M, Strauer BE
  • Med Klin (Munich). 2002 Sep 15;97(9):513-21.
    The current status of noninvasive cardiac diagnosis in women with suspected coronary heart disease.
    Schannwell CM, Lazica D, Plehn G, Leschke M, Strauer BE
  • Z Kardiol. 2001 Sep;90(9):621-9.
    Left ventricular diastolic function parameters after PTCA and stent Implantation.
    Schannwell CM, Schoebel FC, Schmitz M, Leschke M, Strauer BE
  • Z Kardiol. 2001 Jun;90(6):427-36.
    Left ventricular diastolic function in pregnancy in patients with arterial hypertension. A prospective study with M-mode echocardiography and Doppler echocardiography.
    Schannwell CM, Schmitz L, Schoebel FC, Zimmermann T, Marx R, Plehn G, Leschke M, Strauer BE
  • Z Kardiol. 2001 Apr;90(4):269-79.
    Prognostic relevance of left ventricular diastolic function parameters in dilated cardiomyopathy.
    Schannwell CM, Schoebel FC, Marx R, Plehn G, Leschke M, Strauer BE
  • Dtsch Med Wochenschr. 2001 Mar 9;126(10):263-7.
    Can pathological left ventricular hypertrophy in arterial hypertension be distinguished from physiological hypertrophy caused by sports?
    Schannwell CM, Marx R, Plehn G, Perings C, Leschke M, Strauer BE
  • Dtsch Med Wochenschr. 2000 Nov 24;125(47):1417-23.
    Differences in the clinical performance and initial diagnosis in women with suspected coronary artery disease.
    Schannwell CM, Schoebel FC, Lazica D, Marx R, Plehn G, Leschke M, Strauer BE
  • Dtsch Med Wochenschr. 2000 Sep 15;125(37):1069-73.
    Left ventricular diastolic function in normal pregnancy. A prospective study using M-mode echocardiography and Doppler echocardiography.
    Schannwell CM, Schoebel FC, Zimmermann T, Marx R, Plehn G, Leschke M, Strauer BE
  • Z Rheumatol. 2000 Jun;59(3):200-4.
    A rare cause of muscle pain and elevated creatine kinase level--the paroxysmal non-hereditary angioedema.
    Fischer R, Peters A, Klein M, Leschke M, Schneider M
  • Heart. 2000 May;83(5):551-6.
    Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial.
    Heintzen MP, Heidland UE, Klimek WJ, Leschke M, Kelm M, Schwartzkopff B, Vester EG, Michel CJ, Strauer BE
  • Z Kardiol. 1999 Nov;88(11):955-62.
    PTCA of the LAD via the internal thoracic artery graft with Doppler ultrasonic control of the results: a case report and review of the literature.
    Marx R, Jax TW, Plehn G, Schannwell CM, Schoebel FC, Leschke M, Strauer BE
  • Med Klin (Munich). 1999 Nov 15;94(11):633-7.
    Clinical course and complications of meningococcal septicemia.
    Gradaus F, Klein RM, von Giesen HJ, Arendt G, Heintzen MP, Leschke M, Strauer BE
  • J Am Coll Cardiol. 1999 Aug;34(2):486-93.
    Changes of hemostasis, endogenous fibrinolysis, platelet activation and endothelins after percutaneous transluminal coronary angioplasty in patients with stable angina.
    Borries M, Heins M, Fischer Y, Stiegler H, Peters A, Reinauer H, Schoebel FC, Strauer BE, Leschke M
  • Pneumologie. 1999 May;53(5):249-54.
    Influence of pulmonary hemodynamics on right ventricular ejection fraction in chronic obstructive pulmonary disease.
    Steiner S, Peters AJ, Schwalen A, Leschke M, Perings C, Strauer BE
  • Z Kardiol. 1999 May;88(5):338-46.
    Early decrease in diastolic function in young type I diabetic patients as an initial manifestation of diabetic cardiomyopathy.
    Schannwell CM, Schoebel FC, Heggen S, Marx R, Perings C, Leschke M, Strauer BE
  • Respiration. 1999;66(3):225-32.
    Repetitive hemodilution in chronic obstructive pulmonary disease and pulmonary hypertension: effects on pulmonary hemodynamics, gas exchange, and exercise capacity.
    Borst MM, Leschke M, König U, Worth H
  • Pneumologie. 1998 Dec;52(12):694-9.
    Results and complications of fiber bronchoscopy in HIV positive patients.
    Steiner S, Schwalen A, Klein RM, Jablonowski H, Thomas L, Perings C, Strauer BE, Leschke M
  • Dtsch Med Wochenschr. 1998 Nov 20;123(47):1419-25. Review.
    Treatment of coronary heart disease in patients with diabetes mellitus.
    Gradaus F, Leschke M, Jax TW, Schannwell CM, Schoebel FC, Strauer BE
  • Int J Angiol. 1999 Jan;8(1):44-49.
    Long-term Urokinase Therapy and Isovolemic Hemodilution: A Clinical and Hemodynamic Comparison in Patients with Refractory Angina Pectoris.
    Peters AJ, Schoebel FC, Jax TW, Neubaur TER, Strauer BE, Leschke M
  • Z Kardiol. 1998;87 Suppl 2:188-92. Review.
    Assessment of the anti-ischemic effect in patients with therapy refractory angina pectoris in end-stage coronary heart disease--results of chronic intermittent urokinase therapy.
    Schoebel FC, Peters AJ, Schannwell CM, Holz B, Jax TW, Leschke M, Strauer BE
  • Z Kardiol 1998;87 Suppl 2:145-51. Review.
    Antithrombotic therapy in chronic coronary syndromes--value of thrombocyte aggregation inhibition, anticoagulation and chronic thrombolysis.
    Leschke M, Schoebel FC, Stiegler H, Fischer Y, Schannwell CM, Strauer BE
  • Z Kardiol. 1998;87 Suppl 2:80-6. Review.
    Internal thoracic artery bypass--basic principles of Doppler ultrasound for pre- and postoperative diagnosis.
    Marx R, Jax T, Schoebel FC, Schannwell CM, Plehn G, Leschke M, Strauer BE
  • Dtsch Med Wochenschr. 1998 Sep 4;123(36):1030-4.
    Angina pectoris in "coronary steal syndrome" caused by a coronary fistula in the left ventricle.
    Gradaus F, Peters AJ, Schoebel FC, Gradaus D, Leschke M, Strauer BE
  • Dtsch Med Wochenschr. 1998 Aug 14;123(33):957-64.
    Diastolic function parameters and atrial arrhythmias in patients with arterial Hypertension.
    Schannwell CM, Schoebel FC, Badiian M, Jax TW, Marx R, Plehn G, Perings C, Vester EG, Leschke M, Strauer BE
  • Br J Haematol. 1998 Sep;102(4):1108-9.
    Anaphylactic reaction to liposomal amphotericin (AmBisome).
    Schneider P, Klein RM, Dietze L, Söhngen D, Leschke M, Heyll A
  • Z Kardiol. 1998 Apr;87(4):249-57.
    Duplex ultrasound risk stratification of percutaneous puncture of the brachial artery for diagnostic and interventional coronary angiography.
    Rath J, Ganschow US, Kelm M, Leschke M, Vester EG, Heintzen MP, Schwartzkopff B, Strauer BE
  • Circulation. 1998 May 12;97(18):1874-5.
    Functional evaluation of lipid-lowering therapy by pravastatin.
    Schoebel FC, Jax TW, Strauer BE, Leschke M
  • Z Kardiol. 1997 Dec;86(12):961-7.
    Intracoronary dipyridamole reduces the incidence of acute coronary vessel occlusion in percutaneous transluminal coronary angioplasty--a prospective randomized study.
    Heintzen MP, Heidland UE, Klimek WJ, Michel CJ, Kelm M, Leschke M, Schwartzkopff B, Vester EG, Strauer BE
  • Nephrol Dial Transplant. 1998 Jan;13(1):76-81.
    Haemolytic-uraemic syndrome and thrombotic-thrombocytopenic purpura in adults: clinical findings and prognostic factors for death and end-stage renal disease.
    Hollenbeck M, Kutkuhn B, Aul C, Leschke M, Willers R, Grabensee B
  • Herz. 1997 Oct;22(5):262-71. Review.
    Conservative therapeutic approaches in terminal coronary heart disease. Chronic intermittent urokinase therapy.
    Leschke M, Schoebel FC, Jax TW, Schannwell CM, Marx R, Strauer BE
  • Lancet. 1998 Jan 10;351(9096):143.
    Antibodies to cytomegalovirus or Chlamydia pneumoniae and coronary heart disease.
    Stiegler H, Kolbe-Busch S, Fischer Y, Leschke M, Reinauer H
  • Heart. 1997 Oct;78(4):337-42.
    Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography.
    Schoebel FC, Gradaus F, Ivens K, Heering P, Jax TW, Grabensee B, Strauer BE, Leschke M
  • Am Heart J. 1997 Oct;134(4):587-602. Review.
    Refractory angina pectoris in end-stage coronary artery disease: evolving therapeutic concepts.
    Schoebel FC, Frazier OH, Jessurun GA, De Jongste MJ, Kadipasaoglu KA, Jax TW, Heintzen MP, Cooley DA, Strauer BE, Leschke M
  • Dtsch Med Wochenschr. 1997 Aug 1;122(31-32):976-82. Review.
    Coronary heart disease in patients with end-stage kidney failure.
    Leschke M, Gradaus F, Schoebel FC, Ivens K, Heering P, Klein M, Schulte HD, Grabensee B, Strauer BE
  • Pneumologie. 1997 Jun;51(6):580-5.
    Prognostically relevant parameters in patients with coronary heart disease, arterial hypertension and sleep apnea disorders.
    Peters AJ, Perings C, Schwalen A, Steiner S, Hennersdorf M, Strauer BE, Leschke M
  • Nephrol Dial Transplant. 1997 Jun;12(6):1187-91.
    Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy.
    Koch M, Gradaus F, Schoebel FC, Leschke M, Grabensee B
  • Z Kardiol. 1997 May;86(5):373-9.
    Rate of restenosis after PTCA in patients with terminal renal failure. A quantitative coronary angiography study.
    Gradaus F, Schoebel FC, Ivens K, Jax TW, Heering P, Strauer BE, Leschke M
  • Thromb Haemost. 1997 May;77(5):970-4.
    Activation of the fibrinolytic system in patients with coronary artery disease and hyperfibrinogenemia.
    Stein D, Heins M, Schoebel FC, Pels K, Jax TW, Stiegler H, Reinauer H, Strauer BE, Leschke M
  • Z Kardiol. 1997 Apr;86(4):264-72.
    Incidence and therapy of peripheral arterial vascular complications after heart catheter examinations.
    Heintzen MP, Schumacher T, Rath J, Ganschow U, Schoebel FC, Grabitz K, Vester EG, Leschke M, Köhler M, Strauer BE
  • Dtsch Med Wochenschr. 1997 Mar 14;122(11):346-7.
    Blood vessel occlusion in acute and chronic coronary syndromes--significance of PTCA.
    Schoebel FC, Leschke M, Strauer BE
  • Eur J Med Res. 1997 Feb 21;2(2):62-6.
    Long-term survival of recipients of allogeneic bone-marrow transplantation after mechanical ventilation.
    Hollmig KA, Soehngen D, Leschke M, Kobbe G, Schneider P, Klein RM, Aul C, Heyll A
  • Clin Hemorheol Microcirc. 1997 Jan-Feb;17(1):59-66. Review.
    Low-dose intermittent urokinase therapy in chronic symptomatic end-stage arterial disease--clinical relevance for patients with coronary artery disease or peripheral arterial occlusive disease.
    Leschke M, Schoebel FC, Strauer BE
  • Z Kardiol. 1997;86 Suppl 1:85-94. Review.
    Chronic intermittent urokinase therapy: anti-ischemic and hemodynamic effects.
    Leschke M, Schoebel FC, Schannwell CM, Peters AJ, Jax TW, Mecklenbeck W, Strauer BE
  • Z Kardiol. 1997;86 Suppl 1:71-83.
    Significance of coronary thrombosis for chronic myocardial ischemia.
    Schoebel FC, Gradaus F, Jax TW, Stiegler HM, Stein DA, Borries M, Kelm M, Strauer BE, Leschke M
  • Z Kardiol. 1997;86 Suppl 1:V-VI.
    Therapy refractory end stage angina pectoris in coronary heart disease--a clinical and scientific challenge.
    Leschke M, Schoebel FC, Strauer BE
  • Internist (Berl). 1997 Jan;38(1):44-52. Review.
    Interventional therapy in acute myocardial infarct.
    Heintzen MP, Michel CJ, Schlüter S, Leschke M, Schwartzkopff B, Vester EG, Kelm M, Schiele TM, Strauer BE
  • Heart. 1997 Jan;77(1):13-7. Review.
    Antithrombotic treatment in stable coronary syndromes: long-term intermittent urokinase therapy in end-stage coronary artery disease and refractory angina pectoris.
    Schoebel FC, Jax TW, Fischer Y, Strauer BE, Leschke M.
  • J Cardiovasc Risk. 1996 Oct;3(5):465-71.
    Selective impairment of nitric oxide dependent vasodilation in young adults with hypercholesterolaemia.
    Preik M, Kelm M, Schoebel F, Schottenfeld Y, Leschke M, Strauer BE
  • Z Kardiol. 1996 Oct;85(10):761-7.
    Endothelin and big endothelin in coronary heart disease and acute coronary syndromes.
    Borries M, Heins M, Fischer Y, Stiegler H, Schoebel FC, Reinauer H, Strauer BE, Leschke M
  • Nephrol Dial Transplant. 1996 Oct;11(10):1949-51. Review.
    Percutaneous coronary angioplasty (PTCA) or coronary artery bypass grafting (CABG)--which is the appropriate therapy of coronary artery disease in uraemic patients?
    Ivens K, Heering P, Leschke M, Grabensee B
  • Am J Cardiol. 1996 Sep 15;78(6):720-1.
    Acute myocardial infarction with origin of the left circumflex coronary artery from the right (anterior) aortic sinus with retroaortic course to the left atrioventricular sulcus.
    Schoebel FC, Heintzen MP, Jax TW, Gradaus F, Perings C, Trappe HJ, Leschke M, Strauer BE
  • Med Klin (Munich). 1996 Jul 15;91(7):458-65. Review.
    Conservative treatment concepts for stable angina pectoris in coronary heart disease.
    Schoebel FC, Leschke M, Heintzen MP, Strauer BE
  • Pneumologie. 1996 Jul;50(7):469-73.
    A Q-fever pneumonia epidemic in Dusseldorf.
    Schulze K, Schwalen A, Klein RM, Thomas L, Leschke M, Strauer BE
  • Dtsch Med Wochenschr. 1996 Jun 14;121(24):788-92.
    Cardiosurgical therapy of coronary heart disease in terminal kidney insufficiency.
    Ivens K, Heering P, Leschke M, Strauer B, Klein M, Schulte HD, Grabensee B
  • Internist (Berl). 1996 Jun;37(6):597-606. Review.
    Symptomatic therapy refractory myocardial ischemia in coronary heart disease. Chronic intermittent urokinase therapy and invasive therapeutic measures.
    Leschke M, Schoebel FC, Strauer BE
  • Dtsch Med Wochenschr. 1996 Mar 8;121(10):310-7. Review.
    Unstable angina pectoris. Pathogenesis, risk assessment and therapy.
    Schoebel FC, Stein D, Borries M, Heins M, Heintzen MP, Leschke M, Strauer BE
  • J Am Coll Cardiol. 1996 Mar 1;27(3):575-84.
    Long-term intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris: a randomized dose-response trial.
    Leschke M, Schoebel FC, Mecklenbeck W, Stein D, Jax TW, Müller-Gärtner HW, Strauer BE
  • Dtsch Med Wochenschr. 1996 Feb 2;121(5):151.
    Lipoprotein(a) and hemostasis-activation markers in angina pectoris.
    Stein D, Schoebel FC, Leschke M
  • Clin Cardiol. 1996 Feb;19(2):115-20.
    Chronic-intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris--a pilot study.
    Schoebel FC, Leschke M, Jax TW, Stein D, Strauer BE
  • Z Kardiol. 1996 Jan;85(1):1-5.
    Isovolemic hemodilution in coronary heart disease--clinical and hemodynamic effects.
    Neubaur TE, Peters A, Schobel FC, Leschke M, Strauer BE
  • Dtsch Med Wochenschr. 1995 Nov 3;120(44):1495-501.
    Acute myocardial ischemia in spontaneous coronary artery spasm.
    Klein RM, Niehues R, Heintzen MP, Leschke M, Strauer BE
  • Dtsch Med Wochenschr. 1995 Oct 6;120(40):1349-55.
    Cyclosporin in severe steroid-requiring bronchial asthma.
    Klein RM, Leschke M, Strauer BE
  • Dtsch Med Wochenschr. 1995 Mar 3;120(9):301-7. Review.
    Therapy-refractory angina pectoris. Pathophysiologic basis and evaluation of alternative therapies.
    Schoebel FC, Leschke M, Strauer BE
  • Dtsch Med Wochenschr. 1995 Jan 5;120(1-2):45-6.
    How selective are cardioselective beta-receptor blockers?
    Leschke M, Strouer BE
  • Z Kardiol. 1994 Sep;83(9):634-40.
    Percutaneous transluminal therapy of local arterial vascular occlusion after heart catheterization studies.
    Heintzen MP, Motz W, Leschke M, Schumacher T, Vester EG, Strauer BE
  • Dtsch Med Wochenschr. 1994 Jul 29;119(30):1023-8.
    Acute coronary artery occlusion after elective percutaneous transluminal coronary angioplasty. Incidence and therapy in 5000 consecutive patients.
    Heintzen MP, Motz W, Leschke M, Körholz NP, Schultheiss HP, Horstkotte D, Schmitt HH, Vester EG, Preusse CJ, Schulte HD, et al.
  • Bone Marrow Transplant. 1994 Jul;14(1):161-4.
    Possible transmission of sarcoidosis via allogeneic bone marrow transplantation.
    Heyll A, Meckenstock G, Aul C, Söhngen D, Borchard F, Hadding U, Mödder U, Leschke M, Schneider W
  • Z Kardiol. 1994 Jun;83(6):404-13.
    PTCA in the acute state of myocardial infarct: hospital course of 785 consecutive patients.
    Heintzen MP, Motz W, Leschke M, Schultheiss HP, Horstkotte D, Vester EG, Wahbe L, Ries T, Pütz H, Sommer P, et al.
  • Z Kardiol. 1993 Nov;82(11):742-5.
    Report on the "Angiology" Study Group Meeting in Mannheim 15 April 1993.
    Leschke M, Strauer BE, Köhler M
  • Eur Heart J. 1992 Sep;13 Suppl D:96-9.
    Reduced peripheral and coronary vasomotion in systemic hypertension.
    Leschke M, Schoebel FC, Vogt M, Heintzen M, Kelm M, Motz W, Strauer BE
  • Med Klin (Munich). 1992 Jul 15;87(7):385-9.
    Chronic intermittent urokinase therapy in inoperable end-stage coronary disease with therapy refractory angina pectoris symptoms.
    Leschke M, Mecklenbeck W, Strauer BE
  • Dtsch Med Wochenschr. 992 Jan 17;117(3):81-7.
    Chronic intermittent urokinase therapy in therapy-refractory angina pectoris.
    Leschke M, Höffken H, Motz W, Blanke H, Schöbel F, Strauer BE
  • Z Kardiol. 1991 Sep;80(9):585-7.
    Principles, epidemiology and pharmacotherapeutic interventions in atherosclerosis.
    Leschke M, Strauer BE
  • Verh Dtsch Ges Inn Med. 1991;97:511-5. Review.
    Interactions between vascular endothelium and blood rheology.
    Leschke M, Strauer BE
  • Am J Cardiol. 1990 Apr 3;65(14):56G-59G.
    Blood rheology as a contributing factor in reduced coronary reserve in systemic hypertension.
    Leschke M, Vogt M, Motz W, Strauer BE
  • Arzneimittelforschung. 1990 Mar;40(3A):356-62. Review.
    The significance of rheologic mechanisms in atherogenesis.
    Leschke M, Strauer BE
  • Dtsch Med Wochenschr. 1990 Jan 5;115(1):3-7.
    Acute effects of extracorporeal LDL cholesterol and fibrinogen elimination on blood rheology and microcirculation.
    Kleophas W, Leschke M, Tschöpe D, Martin J, Schauseil S, Schottenfeld Y, Strauer BE, Gries FA.
  • Klin Wochenschr. 1990;68 Suppl 22:89-94.
    Rheologic changes in the postprandial phase.
    Leschke M, Saddig C, Kleophas W, Toeller M, Reinauer H, Strauer BE
  • Dtsch Med Wochenschr. 1989 Jun 16;114(24):939-44.
    Effect of fenofibrate on fibrinogen concentration and blood viscosity. Consequences for myocardial microcirculation in coronary heart disease?
    Leschke M, Höffken H, Schmidtsdorff A, Blanke H, Egbring R, Joseph K, Strauer BE
  • Fortschr Med. 1988 Sep 30;106(28):568-70. Review.
    Rheologic risk factors in coronary heart disease.
    Leschke M, Kaffarnik H, Strauer BE
  • Dtsch Med Wochenschr. 1988 Jul 29;113(30):1175-81.
    Hyperfibrinogenemia and pathological plasma viscosity. Pathogenetic factors in unstable angina pectoris?
    Leschke M, Blanke H, Stellwaag M, Motz W, Strauer BE
  • Am J Nephrol. 1988;8(6):449-53.
    Blood rheology and hypertension in hemodialysis patients treated with erythropoietin.
    Schaefer RM, Leschke M, Strauer BE, Heidland A
  • Klin Wochenschr. 1987 Aug 17;65(16):757-63.
    Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin.
    Blanke H, Praetorius G, Leschke M, Seitz R, Egbring R, Strauer BE
  • Dtsch Med Wochenschr. 1987 Jan 16;112(3):96-9.
    Heparin-induced thrombopenia.
    Blanke H, Leschke M, Strauer BE
  • J Cardiovasc Pharmacol. 1987;10 Suppl 6:S153-60.
    Effect of intravenous nifedipine on hemodynamics and left ventricular function in acute myocardial infarction.
    Blanke H, Leschke M, Motz W, Strauer BE
  • J Cardiovasc Pharmacol. 1987;10 Suppl 6:S103-10.
    Blood rheology in hypertension and hypertensive heart disease.
    Leschke M, Motz W, Blanke H, Strauer BE
  • Wien Med Wochenschr. 1986;136 Spec No:17-24.
    Hemorheologic therapy applications in coronary heart disease.
    Leschke M, Motz W, Strauer BE
  • Klin Wochenschr. 1984 Mar 15;62(6):274-7.
    Serum levels and urine excretion of L-carnitine in patients with normal and impaired kidney function.
    Leschke M, Rumpf KW, Eisenhauer T, Becker K, Bock U, Scheler F
  • Biorheology Suppl. 1984;1:231-40.
    Recent progress in improving data processing in filtration measurements.
    Teitel P, Malotta H, Leschke M, Schmid-Schönbein H
  • Kidney Int Suppl. 1983 Dec;16:S143-6.
    Quantitative assessment of carnitine loss during hemodialysis and hemofiltration.
    Leschke M, Rumpf KW, Eisenhauer T, Fuchs C, Becker K, Köthe U, Scheler F
  • Dtsch Med Wochenschr. 1983 Feb 18;108(7):266-8.
    Diagnosis in myoglobinuria.
    Rumpf KW, Kaiser H, Leschke M, Scheler F
  • Proc Eur Dial Transplant Assoc. 1983;19:298-301.
    Quantitative assessment of carnitine loss during haemodialysis and haemofiltration.
    Rumpf KW, Leschke M, Eisenhauer T, Becker K, Köthe U, Scheler F
> vollständige Liste anzeigen

WIR SIND IMMER FÜR SIE DA

Sie möchten einen Termin vereinbaren oder haben eine allgemeine Anfrage?
Sie erreichen mein Sekretariatsteam telefonisch Mo. - Fr. 8.00 - 16.30 Uhr.
Tel.: + 49 711–3103–2401
Fax: + 49 711–3103–2405

Ihre Fragen können Sie uns auch per E-Mail zukommen lassen: m.leschke@klinikum-esslingen.de

Aktuelles

Kardiologischer MittwochKardiologischer Mittwoch 2017/18
> mehr

Medizin Aktuell „Dyspnoe im Spannungsfeld zwischen Herz und Lunge“
> mehr